Mizuho Securities Raises Price Target on Depomed (DEPO) Following Starboard's Activism Announcement; Reiterates Neutral
Get Alerts DEPO Hot Sheet
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE
Mizuho Securities reiterated a Neutral rating on DepoMed Inc (NASDAQ: DEPO), and raised the price target to $18.00 (from $14.00), following Starboard's activism announcement. Mizuho expects the stock to trade in a higher range after Starboard Value disclosed its position in DEPO last week. After touching base with HZNP and DEPO management, and shareholders in both companies, Mizuho believes that a near-term takeout is unlikely.
Analyst Irina Koffler commented, "We are incorporating a 20% probability of company takeout into our DEPO valuation assumptions following Starboard's activism announcement. We expect a drawn-out battle but also acknowledge that this situation should provide support to the stock, even in the face of any weaknesses in the business. We raise our PT to $18 from $14 but reiterate our Neutral rating."
For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.
Shares of DepoMed Inc closed at $16.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 29Metals Ltd (29M:AU) PT Lowered to AUD0.50 at RBC Capital
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- Craig-Hallum Upgrades Lands' End (LE) to Buy, 'the setup looks much better'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeRelated Entities
Starboard ValueSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!